These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Is Kaplan-Meier statistics the most appropriate tool for survivorship measurement of outcomes in orthopaedics?]. Langová K; Gallo J Acta Chir Orthop Traumatol Cech; 2010 Apr; 77(2):118-23. PubMed ID: 20447354 [TBL] [Abstract][Full Text] [Related]
6. Understanding survival analysis: actuarial life tables and the Kaplan-Meier plot. Barakat A; Mittal A; Ricketts D; Rogers BA Br J Hosp Med (Lond); 2019 Nov; 80(11):642-646. PubMed ID: 31707885 [TBL] [Abstract][Full Text] [Related]
7. Measures of follow-up in time-to-event studies: Why provide them and what should they be? Betensky RA Clin Trials; 2015 Aug; 12(4):403-8. PubMed ID: 26025565 [TBL] [Abstract][Full Text] [Related]
8. Survival analysis and Cox regression. Benítez-Parejo N; Rodríguez del Águila MM; Pérez-Vicente S Allergol Immunopathol (Madr); 2011; 39(6):362-73. PubMed ID: 22014655 [TBL] [Abstract][Full Text] [Related]
9. Analysing clinical studies: principles, practice and pitfalls of Kaplan-Meier plots. Ludbrook J; Royse AG ANZ J Surg; 2008 Mar; 78(3):204-10. PubMed ID: 18269491 [TBL] [Abstract][Full Text] [Related]
10. Risk-difference curves can be used to communicate time-dependent effects of adjuvant therapies for early stage cancer. Coory M; Lamb KE; Sorich M J Clin Epidemiol; 2014 Sep; 67(9):966-72. PubMed ID: 24794698 [TBL] [Abstract][Full Text] [Related]
11. A practical guide to understanding Kaplan-Meier curves. Rich JT; Neely JG; Paniello RC; Voelker CC; Nussenbaum B; Wang EW Otolaryngol Head Neck Surg; 2010 Sep; 143(3):331-6. PubMed ID: 20723767 [TBL] [Abstract][Full Text] [Related]
12. The analysis of competing events like cause-specific mortality--beware of the Kaplan-Meier method. Verduijn M; Grootendorst DC; Dekker FW; Jager KJ; le Cessie S Nephrol Dial Transplant; 2011 Jan; 26(1):56-61. PubMed ID: 21059831 [TBL] [Abstract][Full Text] [Related]
13. [Kaplan-Meier analysis]. Tripepi G; Catalano F G Ital Nefrol; 2004; 21(6):540-6. PubMed ID: 15593021 [TBL] [Abstract][Full Text] [Related]
14. Kaplan-Meier Survival, Actuarial Survival, Censoring, and Competing Events-What Is What? Hage A; Hage F Ann Thorac Surg; 2022 Jul; 114(1):40-43. PubMed ID: 35367199 [TBL] [Abstract][Full Text] [Related]
15. Drawing Guideline for Kim J J Korean Med Sci; 2019 Mar; 34(8):e35. PubMed ID: 30833878 [TBL] [Abstract][Full Text] [Related]
16. Understanding Kaplan-Meier and survival statistics. Layton DM Int J Prosthodont; 2013; 26(3):218-26. PubMed ID: 23626973 [TBL] [Abstract][Full Text] [Related]
17. An alternative approach for estimating the number needed to treat for survival endpoints. Yang Z; Yin G PLoS One; 2019; 14(10):e0223301. PubMed ID: 31626655 [TBL] [Abstract][Full Text] [Related]
18. Asymptotic properties of mean survival estimate based on the Kaplan-Meier curve with an extrapolated tail. Gong Q; Fang L Pharm Stat; 2012; 11(2):135-40. PubMed ID: 22323424 [TBL] [Abstract][Full Text] [Related]